Literature DB >> 19280164

[Ethical aspects of aesthetic medicine].

U Wiesing1.   

Abstract

The article examines the question whether and - if - under which conditions physicians should perform purely esthetic interventions. Starting point of the considerations is the special character of the medical profession and the necessity of the anticipated confidence in the system of medicine. The medical measures for aesthetic improvement are systematized. Medical measures to increase the wanted, positively felt attention of others are not compellingly required according to the medical ethic. Nevertheless they do not offend the ethos if high quality standards are insured: The measures must be presumably helpful for the patient; a thorough informed consent and avoidance of damage must be insured. Esthetic measures, in particular operations which are totally cosmetic, should be limited strictly if performed with children and adolescents. Nevertheless convincing arguments support medical-esthetic measures with children and adolescents to avoid stigmatization.

Entities:  

Mesh:

Year:  2009        PMID: 19280164     DOI: 10.1007/s00105-009-1715-3

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  4 in total

1.  The ethics of aesthetic surgery.

Authors:  S R Mousavi
Journal:  J Cutan Aesthet Surg       Date:  2010-01

2.  Improving the Preoperative Diagnostic Accuracy of Acute Appendicitis. Can Fecal Calprotectin Be Helpful?

Authors:  Peter C Ambe; Valerie Orth; Daniel Gödde; Hubert Zirngibl
Journal:  PLoS One       Date:  2016-12-29       Impact factor: 3.240

3.  Surgery of congenital breast asymmetry-which objective parameter influences the subjective satisfaction with long-term results.

Authors:  Vivien Noisser; Andreas Eigenberger; Maximilian Weiherer; Stephan Seitz; Lukas Prantl; Vanessa Brébant
Journal:  Arch Gynecol Obstet       Date:  2021-09-03       Impact factor: 2.344

4.  Calprotectin could be a potential biomarker for acute appendicitis.

Authors:  Peter C Ambe; Daniel Gödde; Lars Bönicke; Marios Papadakis; Stephan Störkel; Hubert Zirngibl
Journal:  J Transl Med       Date:  2016-04-27       Impact factor: 5.531

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.